Nara Organics Infant Formula Recalled Over Botulism Risk, CDC Warns Parents
The Centers for Disease Control and Prevention (CDC) has issued an urgent recall of Nara Organics Whole Milk Organic Infant Formula after linking the product to a multistate outbreak of infant botulism, according to a Saturday evening alert. Three infants in California, Pennsylvania, and Washington developed the rare but serious illness after consuming the formula, with all hospitalized and treated with BabyBIG®, an FDA-approved therapy.
What Products Are Included in the Recall?
The recall encompasses all Nara Organics Whole Milk Organic Infant Formula products, including every lot number and two can sizes sold online and through select retailers nationwide. The company has not yet provided details on the specific lot numbers or expiration dates affected, but health officials are urging parents to stop using the product immediately.
How Does Infant Botulism Occur?
Infant botulism is caused by spores of the bacterium Clostridium botulinum entering an infant’s digestive tract, where they produce toxins that attack nerves, leading to muscular and respiratory paralysis. The condition primarily affects babies under one year old, as their immune systems are still developing. Symptoms may include constipation, feeding difficulties, a weak cry, or loss of head control, though they can take weeks to appear.
What Should Parents Do If They Have the Formula?
The CDC advises parents to discard or return unopened cans of the recalled formula. Those who have already opened containers are encouraged to document the lot number and use-by date and retain the product for up to a month in case it is needed for testing. Health officials also recommend washing bottles, preparation surfaces, and related items with hot, soapy water or a dishwasher.
How Does This Compare to Previous Recalls?
This recall follows a similar incident in 2023, when ByHeart infant formula was linked to 28 confirmed and 20 suspected botulism cases across 17 states. During that recall, Nara Organics was promoted as an alternative, with ByHeart offering a 20% discount to customers. The current outbreak highlights recurring concerns about contamination risks in infant formula, though no deaths have been reported in either incident.
What Is the CDC’s Guidance for Healthcare Providers?
Healthcare providers are advised to treat infant botulism as a clinical diagnosis, initiating treatment with BabyBIG® as soon as the condition is suspected rather than waiting for lab confirmation. Early intervention is critical to preventing severe complications, including respiratory failure. The CDC emphasizes that parents should monitor infants for symptoms for at least a month after their last exposure to the formula.
Why Is This Outbreak Significant?
The recall underscores the vulnerability of infants to foodborne pathogens and the importance of rigorous safety testing in formula production. While infant botulism is rare, with fewer than 100 cases reported annually in the U.S., the illness can be life-threatening if not treated promptly. The CDC continues to investigate the source of contamination, with testing results expected in the coming weeks.